Accordingly, inhibition of the IL6/STAT3 signaling pathway using an IL6 neutralizing antibody or JAK2/STAT3 inhibitor reverses fibroblast-induced invasion and migration of lung cancer cells [149]. Here, IL6 is linked to lung carcinoma.